The global Enteric Disease Testing Market is witnessing steady growth as the prevalence of foodborne, waterborne, and gastrointestinal infections continues to rise worldwide. Enteric disease testing plays a critical role in the rapid detection of bacterial, viral, and parasitic pathogens, enabling timely diagnosis, effective treatment, and improved public health surveillance. Increasing investments in molecular diagnostics, laboratory automation, and point-of-care testing technologies are driving market expansion across hospitals, diagnostic laboratories, and healthcare institutions.

According to Fortune Business Insights, the global enteric disease testing market was valued at USD 4.14 billion in 2025 and is projected to grow from USD 4.27 billion in 2026 to USD 5.47 billion by 2034, exhibiting a CAGR of 3.15% during the forecast period.

Why is the Enteric Disease Testing Market Growing?

The increasing incidence of gastrointestinal infections and foodborne illnesses is one of the primary factors driving the Enteric Disease Testing Market. Healthcare providers and public health agencies are increasingly adopting advanced diagnostic technologies to improve pathogen detection, reduce diagnosis time, and strengthen outbreak management.

Growing awareness regarding early disease diagnosis, expanding investments in molecular diagnostics, and increasing adoption of automated laboratory systems are further accelerating market growth. In addition, continuous advancements in multiplex PCR assays, AI-enabled laboratory platforms, and point-of-care diagnostic solutions are creating significant opportunities for manufacturers and healthcare providers.

Enteric disease testing is widely used for:

• Foodborne disease diagnosis
• Gastrointestinal infection detection
• Hospital laboratory testing
• Public health surveillance
• Clinical diagnostics
• Outbreak investigation
• Waterborne disease monitoring
• Infectious disease management

Growing investments in laboratory modernization and diagnostic innovation continue to create substantial opportunities for market participants.

Key Market Trends Shaping Industry Growth

Rising Adoption of Multiplex Molecular Diagnostics

Healthcare laboratories are increasingly implementing multiplex PCR-based diagnostic systems capable of detecting multiple gastrointestinal pathogens simultaneously with greater accuracy and faster turnaround times.

Growing Demand for Point-of-Care Testing

The increasing need for rapid diagnosis in emergency care, clinics, and remote healthcare settings is driving demand for portable and point-of-care enteric disease testing solutions.